CIC
PRAH
Carnegie Investment Counsel’s PRA Health Sciences, Inc. PRAH Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-19,497
| Closed | -$2.99M | – | 487 |
|
|
2021
Q1 | $2.99M | Sell |
19,497
-82,101
| -81% | -$12.6M | 0.13% | 160 |
|
|
2020
Q4 | $12.7M | Buy |
101,598
+11,119
| +12% | +$1.39M | 0.57% | 56 |
|
|
2020
Q3 | $9.17M | Buy |
90,479
+5,947
| +7% | +$603K | 0.47% | 65 |
|
|
2020
Q2 | $8.22M | Sell |
84,532
-5,350
| -6% | -$520K | 0.47% | 62 |
|
|
2020
Q1 | $7.46M | Sell |
89,882
-6,734
| -7% | -$559K | 0.52% | 62 |
|
|
2019
Q4 | $10.7M | Sell |
96,616
-2,059
| -2% | -$229K | 0.62% | 45 |
|
|
2019
Q3 | $9.79M | Buy |
98,675
+6,173
| +7% | +$613K | 0.62% | 44 |
|
|
2019
Q2 | $9.17M | Buy |
92,502
+23,983
| +35% | +$2.38M | 0.6% | 48 |
|
|
2019
Q1 | $7.56M | Buy |
68,519
+5,394
| +9% | +$595K | 0.52% | 55 |
|
|
2018
Q4 | $5.81M | Sell |
63,125
-13,893
| -18% | -$1.28M | 0.54% | 55 |
|
|
2018
Q3 | $7.76M | Buy |
77,018
+17,052
| +28% | +$1.72M | 0.64% | 42 |
|
|
2018
Q2 | $6.08M | Buy |
59,966
+556
| +0.9% | +$56.4K | 0.46% | 66 |
|
|
2018
Q1 | $4.9M | Buy |
59,410
+22,509
| +61% | +$1.86M | 0.41% | 76 |
|
|
2017
Q4 | $3.26M | Buy |
36,901
+9,800
| +36% | +$865K | 0.29% | 104 |
|
|
2017
Q3 | $2.21M | Buy |
27,101
+8,211
| +43% | +$670K | 0.26% | 110 |
|
|
2017
Q2 | $1.41M | Buy |
18,890
+15,630
| +479% | +$1.17M | 0.17% | 144 |
|
|
2017
Q1 | $225K | Buy |
+3,260
| New | +$225K | 0.03% | 317 |
|